31May
30May
FutureFuel.io launches Giveback, enabling cash back to pay student debt
FutureFuel.io, making the implementation of student debt centric benefits easy has announced the launch of its category-defining offering: Giveback by FutureFuel.io. Read more >>
29May
Legally blind Phenix City man finds sight in electronic glasses
A Phenix City man is among the estimated 200,000 or less people in the United States with an inherited condition called Retinitis Pigmentosa. Moses Fryer was born with Retinitis Pigmentosa. He doesn’t know from whom in his family tree it originated...Fryer could either adapt or try one of the costly electronic glasses approved by the FDA. He chose the eSight glasses. Read more >>
29May
Cloud storage startup Wasabi snags $30M, looks to become unicorn
This article first appeared on BostInno, a sister publication--The round was led by Forestay Capital, the technology innovation arm of Waypoint Capital, with participation from Wasabi’s previous investors. Read more >>
29May
ZetrOZ Systems Announces Dr. George Lewis to Speak at the 2020 National Institutes of Health Pain Consortium Symposium
ZetrOZ Systems is pleased to announce the selection of Dr. George Lewis as a keynote speaker at the 2020 National Institutes of Health Pain Consortium Symposium. Read more >>
28May
Xylyx Bio releases advanced disease model system to improve cancer drug discovery
Xylyx Bio, a leader in predictive disease models, today announced the release of its IN SITE™ Metastasis Kit, a highly physiologic system that contains complex site-specific microenvironments to provide scientists with much-needed insight into cancer disease biology and the efficacy of drug candidates. Read more >>
28May
VIRTUAL Founders Live Boston – May Tech and Startup Pitch Event!
President and CEO of Boston Harbor Angels, Ziad Moukheiber, to speak at expert panel at Founders Live Boston on Thursday, May 28. Read more >>
23May
Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2020 E-Congress that will be taking place June 3-6, 2020. Read more >>
20May
Interview with John O’Neil, Chief Scientific Officer of Xylyx
An inspiration and candid conversation between Dr. Mayasari Lim and upcoming 3DHEALS2020 speaker John O’Neil, Chief Scientific Officer of Xylyx, a New York-based startup focusing on creating the perfect cell environment for a variety of biotech process including biofabrication/bioprinting, and tissue engineering. Read more >>
20May